Stockscreener 앱 받기
1.095
1.35%
-0.015
시간 외 거래:
1.05
-0.045
-4.11%
전일 마감가:
$1.11
열려 있는:
$1.07
하루 거래량:
29,448
Relative Volume:
0.09
시가총액:
$1.11M
수익:
-
순이익/손실:
$-25.85M
주가수익비율:
-0.00083
EPS:
-1319.9757
순현금흐름:
$-14.88M
1주 성능:
-13.78%
1개월 성능:
-32.41%
6개월 성능:
-83.48%
1년 성능:
+181.27%
1일 변동 폭
$1.07
$1.131
1주일 범위
$1.07
$1.27
52주 변동 폭
$0.0927
$15.90
Glucotrack Inc Stock (GCTK) Company Profile
명칭
Glucotrack Inc
전화
972 (8) 675-7878
주소
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
1.095 | 1.12M | 0 | -25.85M | -14.88M | -1,319.98 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
Glucotrack Inc 주식(GCTK)의 최신 뉴스
Growth Recap: Is GlucoTrack Inc backed by strong institutional buying2026 Closing Moves & Short-Term High Return Ideas - baoquankhu1.vn
GlucoTrack Shareholders Approve Capital Flexibility and Auditor Ratification - The Globe and Mail
GlucoTrack, Inc. 8-K SEC Filing: Company Details, Nasdaq Listing, and Key Disclosures (March 2026) - Minichart
Glucotrack shareholders approve stock issuances and auditor ratification - Investing.com
Glucotrack (GCTK) investors approve large stock and warrant issuances - Stock Titan
GCTK SEC FilingsGlucotrack 10-K, 10-Q, 8-K Forms - Stock Titan
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit - Yahoo Finance
Chart Watch: Will GlucoTrack Inc benefit from geopolitical trendsMarket Movement Recap & Safe Capital Growth Plans - baoquankhu1.vn
GCTK Earnings History & Surprises | EPS & Revenue Results | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill
GCTK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
GCTK Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Risk Recap: Should value investors consider GlucoTrack IncJuly 2025 Momentum & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Exit Recap: Can Oaktree Acquisition Corp III Life Sciences Equity Warrant benefit from deglobalization2025 Stock Rankings & Daily Growth Stock Investment Tips - baoquankhu1.vn
Armistice (GCTK) reports 9.99% stake — 101,075 shares disclosed - Stock Titan
Is GlucoTrack Inc. stock a buy before product launchesM&A Rumor & Technical Confirmation Alerts - mfd.ru
Is GlucoTrack Inc. stock a good pick for beginners2025 Technical Patterns & Safe Capital Growth Stock Tips - mfd.ru
Investment Review: Can GlucoTrack Inc beat the S P 500Market Performance Recap & Technical Pattern Alert System - baoquankhu1.vn
A | What makes GlucoTrack, Inc. stock attractive todayProfit Target & Low Risk High Reward Ideas - mfd.ru
Why GlucoTrack Inc. stock is a value investor pickDividend Hike & Daily Growth Stock Investment Tips - mfd.ru
Short Interest in GlucoTrack Surges Over 600% - National Today
Aug Summary: Can GlucoTrack Inc beat the S P 500Market Activity Recap & Fast Gain Stock Tips - baoquankhu1.vn
Varex Imaging Outperforms GlucoTrack in Analyst Comparisons - National Today
GlucoTrack (NASDAQ:GCTK) and Varex Imaging (NASDAQ:VREX) Financial Survey - Defense World
Why did Glucotrack stock surge 12% pre-market today? - MSN
Earnings Risk: Will GlucoTrack Inc benefit from current market trendsJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - baoquankhu1.vn
US Market Wrap: Will Voyager Acquisition Corp Equity Warrant benefit from current market trendsPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Why Did Glucotrack Stock Surge 12% Pre-Market Today? - Stocktwits
Glucotrack secures three patents for implantable glucose monitor By Investing.com - Investing.com Nigeria
Glucotrack Announces 3 New Patents to Monitor Blood Glucose - Yahoo Finance
Glucotrack, Inc. (GCTK) stock: slides 30% despite trio of fresh USPTO patents for implantable CBGM platform - parameter.io
GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform - TipRanks
GlucoTrack’s Share Offering Spurs Market Activity - StocksToTrade
Glucotrack Stumbles Despite Winning Patent - Baystreet.ca
Glucotrack, Inc. Announces USPTO Approval for CBGM Patents - TradingView
Glucotrack secures three patents for implantable glucose monitor - Investing.com
Glucotrack stock soars after USPTO approves patents for glucose monitoring tech - Investing.com Nigeria
Glucotrack stock soars after USPTO approves patents for glucose monitoring tech By Investing.com - Investing.com South Africa
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - marketscreener.com
Implantable glucose sensor designed for 3 years, backed by new US patents - stocktitan.net
Published on: 2026-01-29 16:41:28 - baoquankhu1.vn
History Review: Can First BanCorp grow without external fundingJuly 2025 Closing Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Market Review: Can WETH lead its sector in growthJuly 2025 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Update: Is Strategic Education Inc likely to announce a buybackJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
GlucoTrack (NASDAQ:GCTK) Trading 2.9% Higher – Here’s What Happened - Defense World
Highs Report: Is GlucoTrack Inc impacted by rising ratesInflation Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
How GlucoTrack Inc. stock performs in rising dollar environmentEarnings Recap Report & Risk Managed Trade Strategies - bollywoodhelpline.com
Risk Analysis: Can GlucoTrack Inc beat the S P 5002025 Market Overview & Weekly High Return Stock Forecasts - baoquankhu1.vn
Will GlucoTrack Inc. stock reach all time highs in 20252025 Trade Ideas & Fast Exit/Entry Strategy Plans - ulpravda.ru
Why GlucoTrack Inc. stock remains undervaluedTrade Risk Summary & AI Powered Buy and Sell Recommendations - Улправда
Is GlucoTrack Inc. stock positioned well for digital economyWeekly Gains Report & Growth Focused Entry Reports - Улправда
Is GlucoTrack Inc. stock supported by strong fundamentalsJuly 2025 Patterns & AI Powered Trade Plan Recommendations - Улправда
Glucotrack Inc (GCTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.65%
자본화:
|
볼륨(24시간):